Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ACRA-CUT is a U.S. medical device company focused on neurosurgical instruments, especially cranial perforators used to create skull openings during neurosurgical procedures. The company has stated that it has operated in the cranial perforator market since 1981 and is based in Acton, Massachusetts. Its commercial product portfolio includes disposable and reusable cranial perforators, scalp clip systems, cranioblades, hand instruments, distraction screws, and related accessories for adult and pediatric neurosurgery. ACRA-CUT positions itself as a specialist in automatic-releasing cranial perforator technology and serves hospitals and neurosurgical customers. In March 2026, Nakanishi announced that its U.S. subsidiary NSK America agreed to acquire ACRA-CUT, with share transfer planned for April 1, 2026.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ACRA-CUT.